Boc-L-Met-ONp

Boc-L-Met-ONp is a protected L-methionine derivative bearing a Boc-protected alpha-amino group and an ONp (p-nitrophenyl) ester at the carboxyl position, combining peptide-compatible protection with an activated ester functionality. This structure is widely used as a coupling-ready building block in peptide synthesis workflows, where the ONp ester enables efficient amide bond formation under standard peptide coupling conditions. The methionine thioether side chain provides a chemically distinctive, sulfur-containing functionality that is commonly retained through assembly steps for subsequent peptide or conjugate handling.

1. Peptide Bond Coupling

Boc-L-Met-ONp is used by peptide synthesis groups to introduce the L-methionine residue during segment assembly and stepwise chain elongation, leveraging the activated ONp ester for amide bond formation. Researchers in custom peptide manufacturing and academic peptide chemistry frequently select this format to streamline coupling of methionine-containing sequences while maintaining the Boc-protected amino group for controlled reactivity across protected building blocks. The ONp leaving group supports practical coupling workflows where activated esters are preferred over less reactive carboxylic acid forms, and the Boc protection helps ensure orthogonal control relative to other protected residues in the same synthesis.

2. Fmoc/Boc-Compatible Intermediate Synthesis

Boc-L-Met-ONp is commonly handled as a protected amino acid intermediate for preparing methionine-containing peptide segments and activated derivatives used in solution-phase or fragment condensation strategies. Medicinal chemistry groups developing peptidomimetic scaffolds often rely on activated ester building blocks to generate well-defined coupling partners for downstream assembly, especially when methionine must be installed at a specific position within a protected sequence. The combination of Boc on nitrogen and ONp activation on the carboxyl group makes this reagent a practical node in protected intermediate workflows, supporting controlled progression from amino acid building blocks toward longer protected peptides.

3. Methionine-Containing Peptide Libraries

Boc-L-Met-ONp supports peptide library construction where methionine residues are required to probe sequence-dependent properties, including sulfur-containing side-chain effects on chemical stability and local peptide microenvironment. Peptide discovery teams and chemical biology laboratories often use activated amino acid esters to rapidly generate multiple analogs by varying neighboring residues while keeping the methionine position consistent. In these workflows, the reagent's protected form helps maintain compatibility with standard protected-residue strategies, while the ONp activation enables efficient coupling during parallel synthesis or iterative library expansion.

4. Pharmaceutical Intermediate Development

Boc-L-Met-ONp is also used in the development of methionine-containing pharmaceutical intermediates, particularly when a protected amino acid unit must be incorporated into larger protected intermediates prior to final deprotection and functional group tailoring. Process development and specialty synthesis teams value activated amino acid derivatives for their predictable reactivity in intermediate assembly, reducing variability associated with less activated carboxylic acid starting materials. The Boc/ONp protection pattern provides a controlled platform for building protected structures that can later be converted into the corresponding peptide-like intermediates used in further synthetic steps.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

3. Myotropic activity of allatostatins in tenebrionid beetles

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII